Rejoinder to the letter: "Standard and reference-based conditional mean imputation: Regulators and trial statisticians be aware!"

Pharm Stat. 2024 Apr 17. doi: 10.1002/pst.2374. Online ahead of print.
No abstract available

Publication types

  • Letter